Freedom4um

Status: Not Logged In; Sign In

ObamaNation
See other ObamaNation Articles

Title: Pfizer Doses First Patient In Phase 2/3 Trial For Daily COVID Pill
Source: zerohedge
URL Source: https://www.zerohedge.com/covid-19/ ... ase-23-trial-covid-therapeutic
Published: Sep 2, 2021
Author: Tyler Durden
Post Date: 2021-09-02 14:44:26 by Esso
Keywords: None
Views: 40

Pfizer revealed on Wednesday that it had finally dosed its first patient participating in the Phase 2/3 study examining the efficacy of PF- 07321332, an orally administered protease inhibitor antiviral designed to combat COVID-19.

The randomized, double-blind trial will enroll approximately 1,140 participants, who will receive PF07321332/ritonavir, or a placebo, orally every 12 hours for five days.

Pfizer CEO Albert Bourla weighed in via tweet:

Click for Full Text!


Poster Comment:

WTAF?

Post Comment   Private Reply   Ignore Thread